🔎︎
Why do regular cannabis users show lower rates of obesity and type 2 diabetes despite the drug's appetite-stimulating reputation? A study published in The Journal of Physiology probes that paradox at the bench. Researchers led by Bryant Avalos at the University of California, Riverside, note that cannabis users are roughly half as likely to develop type 2 diabetes as non-users, and they gave obese mice daily THC or a whole-cannabis extract matched for THC content for 30 days, then examined body weight, glucose handling, fat tissue, and the body's endocannabinoid signaling system.
Both THC and the full extract reduced body weight and visceral fat in mice fed a high-fat, high-sugar diet, even though the animals continued to eat about the same amount and did not move more, suggesting a metabolic rather than a behavioral effect. The sharper split came with blood sugar. The whole extract, but not THC alone, normalized glucose clearance to levels seen in lean mice and improved insulin sensitivity, while both treatments lowered fasting glucose and insulin and shrank enlarged fat cells. The extract also more fully restored normal expression of adipokines, the fat-derived signals that help govern the adipoinsular axis linking fat tissue to insulin.
The authors attribute the extract's edge to minor cannabinoids such as CBD and THCV working alongside THC, and to a calming of the overactive endocannabinoid tone that accompanies obesity. Experiments in cultured fat cells supported the picture, showing reduced lipid accumulation and shifts in cellular energy metabolism.
For managed care audiences tracking the metabolic-disease pipeline, the work is worth noting but not acting on. It is preclinical, conducted only in male mice and cell cultures, and the authors describe several findings as hypothesis-generating, calling for work in females, at thermoneutral housing, and eventually in humans. They conclude that cannabinoids, particularly whole extracts, hold potential therapeutic value for obesity and related metabolic disorders, while stressing that the mechanisms and clinical translation remain to be established.
